SolarEdge Technologies (NASDAQ:SEDG) -4.2% in Monday's trading after TD Cowen downgraded shares to Hold from Buy with a $16 ...

TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in ...

Fintel reports that on October 21, 2024, TD Cowen downgraded their outlook for SolarEdge Technologies (NasdaqGS:SEDG) from ...

Yum! Brands (YUM) stock slips after TD Cowen downgrades rating to Hold, citing risks in restaurant unit development and Taco ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Humacyte (HUMA – Research Report) today and set a price target of $10.00. The ...

TD Cowen on potential opportunities in Canadian equities. The potential impact of Canadian mortgage resets in 2025. Why demographic uncertainty could be a major challenge for the Canadian economy.

In a report released today, Daniel Brennan from TD Cowen maintained a Hold rating on 10x Genomics (TXG – Research Report), with a price ...

TD Cowen upgraded Universal Health Services stock from Hold to Buy, catapulting its price target from $220 to $283 per share.Market Domination anchors Julie Hyman and Josh Lipton discuss TD Cowen ...

TD Cowen has maintained its Hold rating on Snap Inc (NYSE: NYSE:SNAP) with a steady price target of $11.00. The firm's analysis projects that Snap will report a slowdown in revenue growth for the ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 10.44% ...

TD Cowen maintained its positive stance on Halozyme (NASDAQ:HALO) Therapeutics (NASDAQ:HALO), reiterating a Buy rating and a price target of $70.00. The endorsement follows recent discussions with ...

TD Cowen upgraded Universal Health Services stock (UHS) from Hold to Buy, catapulting its price target from $220 to $283 per share. Market Domination anchors Julie Hyman and Josh Lipton discuss TD ...